HeartSciences (HSCS) Cash from Investing Activities (2022 - 2026)
HeartSciences filings provide 5 years of Cash from Investing Activities readings, the most recent being -$27868.0 for Q1 2026.
- On a quarterly basis, Cash from Investing Activities fell 77.49% to -$27868.0 in Q1 2026 year-over-year; TTM through Jan 2026 was -$52264.0, a 42.95% increase, with the full-year FY2025 number at -$30188.0, up 75.9% from a year prior.
- Cash from Investing Activities hit -$27868.0 in Q1 2026 for HeartSciences, down from -$15770.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of -$814.0 in Q3 2025 to a low of -$69228.0 in Q2 2024.
- Median Cash from Investing Activities over the past 5 years was -$7419.5 (2022), compared with a mean of -$15587.1.
- Biggest five-year swings in Cash from Investing Activities: plummeted 1317.73% in 2024 and later soared 88.72% in 2025.
- HeartSciences' Cash from Investing Activities stood at -$7247.0 in 2022, then surged by 73.06% to -$1952.0 in 2023, then plummeted by 199.28% to -$5842.0 in 2024, then crashed by 169.94% to -$15770.0 in 2025, then crashed by 76.72% to -$27868.0 in 2026.
- The last three reported values for Cash from Investing Activities were -$27868.0 (Q1 2026), -$15770.0 (Q4 2025), and -$814.0 (Q3 2025) per Business Quant data.